• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why NeoGames Shares Are Trading Higher By 121%; Here Are 20 Stocks Moving Premarket

    5/15/23 8:03:05 AM ET
    $ALGS
    $ATNX
    $BNMV
    $BRSH
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $ALGS alert in real time by email

    Gainers

    • NeoGames S.A. (NASDAQ:NGMS) shares surged 121% to $28.38 in pre-market trading as the company agreed to be acquired by Aristocrat Leisure Limited for $29.50 per share in cash.
    • MGO Global, Inc. (NASDAQ:MGOL) shares rose 60.2% to $1.91 in pre-market trading. MGO Global is scheduled to host a webcast on May 16, 2023 to discuss recent operational developments and financial results for the first quarter.
    • Aligos Therapeutics, Inc. (NASDAQ:ALGS) shares gained 45% to $1.58 in pre-market trading after the company reported a Research collaboration and development agreement with Xiamen Amoytop Biotech Co. Ltd. for the use of Aligos’ oligonucleotide platform for the treatment of liver diseases.
    • GSI Technology, Inc. (NASDAQ:GSIT) shares gained 31% to $6.67 in pre-market trading after jumping 210% on Friday.
    • Peraso Inc. (NASDAQ:PRSO) shares rose 30.2% to $0.47 in pre-market trading. Peraso is expected to release its first-quarter financial results on May 15, 2023 after the closing bell.
    • View, Inc. (NASDAQ:VIEW) shares climbed 25.8% to $0.2798 in pre-market trading. View recently posted a narrower-than-expected quarterly loss.
    • Rackspace Technology, Inc. (NASDAQ:RXT) gained 17.5% to $1.33 in pre-market trading. Rackspace Tech recently posted upbeat Q1 results.
    • WiSA Technologies, Inc. (NASDAQ:WISA) rose 16.4% to $1.84 in pre-market trading. WiSA Technologies is expected to host its first quarter results conference call on May 16, 2023.
    • Edgio, Inc. (NASDAQ:EGIO) rose 12.1% to $0.61 in pre-market trading.
    • Tivic Health Systems, Inc. (NASDAQ:TIVC) gained 11.5% to $0.1984 in pre-market trading ahead of quarterly results.

    Losers

    • Athenex, Inc. (NASDAQ:ATNX) fell 50.6% to $0.5632 in pre-market after the company voluntarily filed for Chapter 11 proceedings.
    • Infobird Co., Ltd (NASDAQ:IFBD) shares dropped 23.1% to $1.00 in pre-market trading. Infobird announced 1-for-5 share consolidation.
    • BitNile Metaverse, Inc. (NASDAQ:BNMV) fell 19.8% to $1.07 in pre-market trading. BitNile Metaverse shares dropped 23% on Friday after the company announced a 1-for-30 reverse stock split.
    • Wearable Devices Ltd. (NASDAQ:WLDS) shares fell 16.1% to $0.4280 in pre-market trading after climbing over 10% on Friday.
    • Meihua International Medical Technologies Co., Ltd. (NASDAQ:MHUA) fell 13.5% to $3.63 in pre-market trading after gaining more than 42% on Friday.
    • Zapp Electric Vehicles Group Limited (NASDAQ:ZAPP) fell 12.5% to $3.35 in pre-market trading after jumping over 25% on Friday.
    • Dermata Therapeutics, Inc. (NASDAQ:DRMA) fell 12.5% to $2.28 in pre-market trading. Dermata Therapeutics shares jumped 35% on Friday after the company provided a corporate update and reported Q1 financial results.
    • ICZOOM Group Inc. (NASDAQ:IZM) fell 12.4% to $2.13 in pre-market trading.
    • Jupiter Wellness Acquisition Corp. (NASDAQ:JWAC) fell 12% to $5.85 in pre-market trading after jumping around 30% on Friday.
    • Bruush Oral Care Inc. (NASDAQ:BRSH) shares dropped 10.3% to $0.2762 in pre-market trading. Brüush, last month, named Mandeek Manhas as new Chief Financial Officer.

     

    Read More: Top 5 Industrials Stocks That May Explode In Q2

    Get the next $ALGS alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ALGS
    $ATNX
    $BNMV
    $BRSH

    CompanyDatePrice TargetRatingAnalyst
    Aligos Therapeutics Inc.
    $ALGS
    3/19/2026$48.00Buy
    Jefferies
    Aligos Therapeutics Inc.
    $ALGS
    8/18/2025$50.00Buy
    H.C. Wainwright
    Rackspace Technology Inc.
    $RXT
    6/2/2025Outperform → Mkt Perform
    Raymond James
    Aligos Therapeutics Inc.
    $ALGS
    8/19/2024$75.00Buy
    H.C. Wainwright
    Rackspace Technology Inc.
    $RXT
    11/7/2023$1.40Neutral
    UBS
    Rackspace Technology Inc.
    $RXT
    9/19/2023$3.50Mkt Perform → Outperform
    Raymond James
    NeoGames S.A.
    $NGMS
    8/14/2023$29.50Buy → Hold
    Jefferies
    NeoGames S.A.
    $NGMS
    8/10/2023$29.50Buy → Hold
    Deutsche Bank
    More analyst ratings

    $ALGS
    $ATNX
    $BNMV
    $BRSH
    SEC Filings

    View All

    SEC Form POS AM filed by Wearable Devices Ltd.

    POS AM - Wearable Devices Ltd. (0001887673) (Filer)

    3/19/26 4:01:50 PM ET
    $WLDS
    Computer Communications Equipment
    Telecommunications

    SEC Form 144 filed by Rackspace Technology Inc.

    144 - Rackspace Technology, Inc. (0001810019) (Subject)

    3/18/26 8:18:29 PM ET
    $RXT
    Computer Software: Programming Data Processing
    Technology

    GSI Technology filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

    8-K - GSI TECHNOLOGY INC (0001126741) (Filer)

    3/18/26 8:30:12 AM ET
    $GSIT
    Semiconductors
    Technology

    $ALGS
    $ATNX
    $BNMV
    $BRSH
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SVP, Regulatory Affairs Bedoya-Toro Munera Maria E bought $1,270 worth of shares (1,000 units at $1.27), increasing direct ownership by 8,333% to 1,012 units (SEC Form 4)

    4 - Dermata Therapeutics, Inc. (0001853816) (Issuer)

    3/17/26 5:44:21 PM ET
    $DRMA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: Director Bradley Jack A. bought $10,650 worth of shares (3,000 units at $3.55) (SEC Form 4)

    4/A - GSI TECHNOLOGY INC (0001126741) (Issuer)

    8/8/25 4:06:09 PM ET
    $GSIT
    Semiconductors
    Technology

    Director Roberts Anthony C. bought $50,583 worth of shares (19,455 units at $2.60), increasing direct ownership by 14% to 161,930 units (SEC Form 4)

    4 - Rackspace Technology, Inc. (0001810019) (Issuer)

    12/9/24 7:14:06 PM ET
    $RXT
    Computer Software: Programming Data Processing
    Technology

    $ALGS
    $ATNX
    $BNMV
    $BRSH
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Jefferies resumed coverage on Aligos Therapeutics with a new price target

    Jefferies resumed coverage of Aligos Therapeutics with a rating of Buy and set a new price target of $48.00

    3/19/26 8:25:43 AM ET
    $ALGS
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    H.C. Wainwright resumed coverage on Aligos Therapeutics with a new price target

    H.C. Wainwright resumed coverage of Aligos Therapeutics with a rating of Buy and set a new price target of $50.00

    8/18/25 8:55:27 AM ET
    $ALGS
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Rackspace Technology downgraded by Raymond James

    Raymond James downgraded Rackspace Technology from Outperform to Mkt Perform

    6/2/25 8:43:53 AM ET
    $RXT
    Computer Software: Programming Data Processing
    Technology

    $ALGS
    $ATNX
    $BNMV
    $BRSH
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Wolf Lisa G

    4 - Tivic Health Systems, Inc. (0001787740) (Issuer)

    3/19/26 9:14:41 PM ET
    $TIVC
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    SEC Form 3 filed by new insider Mualem Alon

    3 - Wearable Devices Ltd. (0001887673) (Issuer)

    3/19/26 4:10:32 PM ET
    $WLDS
    Computer Communications Equipment
    Telecommunications

    SEC Form 3 filed by new insider Fleisher Tamar

    3 - Wearable Devices Ltd. (0001887673) (Issuer)

    3/19/26 4:10:17 PM ET
    $WLDS
    Computer Communications Equipment
    Telecommunications

    $ALGS
    $ATNX
    $BNMV
    $BRSH
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    GSI Technology Concludes Strategic Alternatives Review

    SUNNYVALE, Calif., March 18, 2026 (GLOBE NEWSWIRE) -- GSI Technology, Inc. (NASDAQ:GSIT) today announced that its Board of Directors has concluded the Company's previously announced review of strategic alternatives. In reaching this determination, the Board considered the Company's operational and financial progress and the strengthened balance sheet following the October 2025 capital raise, which provided additional resources to support GSI Technology's go-forward plan. As part of the review, the Board and its advisors engaged with multiple parties and evaluated a range of potential alternatives. After careful consideration, the Board concluded that continuing to execute the Company's st

    3/18/26 8:30:00 AM ET
    $GSIT
    Semiconductors
    Technology

    Rubrik and Rackspace Technology Launch UK Sovereign Cyber Recovery Cloud

    LONDON, March 18, 2026 (GLOBE NEWSWIRE) -- Rackspace Technology® (NASDAQ:RXT), a leading end-to-end hybrid cloud and AI solutions company, and Rubrik, (NYSE:RBRK), the Security and AI Operations Company, today announced UK Sovereign Cyber Recovery Cloud, a new ransomware cyber recovery solution engineered to protect and restore UK public sector and regulated workloads within hours of an attack. As the UK enters a pivotal year for digital sovereignty, new legislation mandates higher standards for organisations' resilience and recovery. To meet these demands, UK Sovereign Cyber Recovery Cloud provides a dedicated, automated "clean room" recovery environment that remains entirely within UK b

    3/18/26 4:00:00 AM ET
    $RBRK
    $RXT
    Computer Software: Prepackaged Software
    Technology
    Computer Software: Programming Data Processing

    Wearable Devices Strengthens AI Advisory Board with Former Google and Qualcomm Executives to Accelerate ai6 Labs' Vision

    Yokneam Illit, Israel, March 16, 2026 (GLOBE NEWSWIRE) -- Wearable Devices Ltd. (NASDAQ:WLDS, WLDSW)) ("Wearable Devices" or the "Company"), a technology growth company specializing in artificial intelligence ("AI")-powered touchless sensing wearables, today announced a significant expansion of its AI expert advisory board. This strategic enhancement strengthens the Company's commitment to advancing neural AI innovation through ai6 Labs. The recently launched ai6 Labs is focused on advancing the Company's revolutionary neural AI technology powered by non-invasive electromyography (EMG) technology and the Mudra platform, supporting a closed-loop ecosystem designed to seamlessly connect hu

    3/16/26 8:45:00 AM ET
    $WLDS
    Computer Communications Equipment
    Telecommunications

    $ALGS
    $ATNX
    $BNMV
    $BRSH
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for FAMOTIDINE issued to ATHENEX INC

    Submission status for ATHENEX INC's drug FAMOTIDINE (SUPPL-13) with active ingredient FAMOTIDINE has changed to 'Approval' on 01/07/2022. Application Category: ANDA, Application Number: 075684, Application Classification: Labeling

    1/12/22 4:41:30 AM ET
    $ATNX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for KLISYRI

    Submission status for ATHENEX INC's drug KLISYRI (ORIG-1) with active ingredient TIRBANIBULIN has changed to 'Approval' on 12/14/2020. Application Category: NDA, Application Number: 213189, Application Classification: Type 1 - New Molecular Entity

    12/20/20 4:30:55 PM ET
    $ATNX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ALGS
    $ATNX
    $BNMV
    $BRSH
    Leadership Updates

    Live Leadership Updates

    View All

    Wearable Devices Strengthens AI Advisory Board with Former Google and Qualcomm Executives to Accelerate ai6 Labs' Vision

    Yokneam Illit, Israel, March 16, 2026 (GLOBE NEWSWIRE) -- Wearable Devices Ltd. (NASDAQ:WLDS, WLDSW)) ("Wearable Devices" or the "Company"), a technology growth company specializing in artificial intelligence ("AI")-powered touchless sensing wearables, today announced a significant expansion of its AI expert advisory board. This strategic enhancement strengthens the Company's commitment to advancing neural AI innovation through ai6 Labs. The recently launched ai6 Labs is focused on advancing the Company's revolutionary neural AI technology powered by non-invasive electromyography (EMG) technology and the Mudra platform, supporting a closed-loop ecosystem designed to seamlessly connect hu

    3/16/26 8:45:00 AM ET
    $WLDS
    Computer Communications Equipment
    Telecommunications

    Joseph Vito Joins Rackspace Technology to Lead Strategic Alliance Partnerships

    SAN ANTONIO, Jan. 27, 2026 (GLOBE NEWSWIRE) -- Rackspace Technology® (NASDAQ:RXT), a leading end-to-end hybrid cloud and AI solutions company, today announced the appointment of Joseph Vito as Senior Vice President of Strategic Alliance Partnerships. In this role, Vito will lead Rackspace's global strategy for building and strengthening technology and channel partnerships that drive innovation and deliver exceptional value to customers. Vito brings more than 25 years of experience in technology leadership, cloud transformation, and enterprise solutions across financial services, life sciences, energy, and consumer manufacturing. Most recently, he served as a Strategic Transformation Princ

    1/27/26 8:15:00 AM ET
    $RXT
    Computer Software: Programming Data Processing
    Technology

    Aligos Therapeutics Strengthens Senior Leadership Team with the Appointment of James Hassard as Executive Vice President, Chief Commercial Officer

    SOUTH SAN FRANCISCO, Calif., Jan. 13, 2026 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (("Aligos", NASDAQ:ALGS), a clinical stage biopharmaceutical company focused on improving patient outcomes through best-in-class therapies for liver and viral diseases, today announced the appointment of James Hassard, MBA as Executive Vice President, Chief Commercial Officer, effective immediately. Mr. Hassard will lead and build the Company's global commercial capabilities and serve as a member of Aligos' Senior Leadership Team. Mr. Hassard is a seasoned executive with extensive experience building commercial organizations across multiple therapeutic areas. "As we continue to progress the Phase 2 B-

    1/13/26 8:00:00 AM ET
    $ALGS
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $ALGS
    $ATNX
    $BNMV
    $BRSH
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Aligos Therapeutics Inc.

    SC 13G/A - Aligos Therapeutics, Inc. (0001799448) (Subject)

    11/14/24 6:57:50 PM ET
    $ALGS
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Amendment: SEC Form SC 13G/A filed by Aligos Therapeutics Inc.

    SC 13G/A - Aligos Therapeutics, Inc. (0001799448) (Subject)

    11/14/24 6:19:11 PM ET
    $ALGS
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    SEC Form SC 13G filed by Meihua International Medical Technologies Co. Ltd.

    SC 13G - Meihua International Medical Technologies Co., Ltd. (0001835615) (Subject)

    11/14/24 6:08:55 PM ET
    $MHUA
    Medical/Dental Instruments
    Health Care

    $ALGS
    $ATNX
    $BNMV
    $BRSH
    Financials

    Live finance-specific insights

    View All

    Wearable Devices Reports Full Year 2025 Financial Results, Highlights Revenue Growth, $24.4 Million Raised in 2025 and $18.4 Million Cash Position

    YOKNE'AM ILLIT, Israel, March 12, 2026 (GLOBE NEWSWIRE) -- Wearable Devices Ltd. (NASDAQ:WLDS, WLDSW)) ("Wearable Devices" or the "Company"), a technology growth company specializing in artificial intelligence ("AI")-powered touchless sensing wearables, today announced its financial results for the year ended December 31, 2025. The Company reported revenue growth for the year, driven in part by a 28.5% increase in sales of its Mudra Link and Mudra Band products, reflecting growing adoption of its gesture-control technology and continued expansion of its business-to-client ("B2C") segment. Management Commentary "We are pleased to conclude 2025 with steady momentum in our B2C sector, drive

    3/12/26 9:00:00 AM ET
    $WLDS
    Computer Communications Equipment
    Telecommunications

    Rackspace Technology Reports Fourth Quarter and Full Year 2025 Results

    Fourth Quarter Revenue of $683 million, down 0.4% Year-over-Year; 2025 Revenue of $2,686 million, down 2% Year-over-YearFourth Quarter Private Cloud Revenue of $241 million, down 10% Year-over-Year; 2025 Private Cloud Revenue of $990 million, down 6% Year-over-YearFourth Quarter Public Cloud Revenue of $442 million, up 6% Year-over-Year; 2025 Public Cloud Revenue of $1,696 million up 1% Year-over-YearFourth Quarter Cash Flow From Operating Activities of $60 million; 2025 Cash Flow From Operating Activities of $151 million SAN ANTONIO, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Rackspace Technology, Inc. (NASDAQ:RXT), a leading end-to-end hybrid cloud and AI solutions company, today announc

    2/26/26 8:00:00 AM ET
    $RXT
    Computer Software: Programming Data Processing
    Technology

    Rackspace Technology to Announce Fourth Quarter 2025 Earnings on February 26, 2026

    SAN ANTONIO, Feb. 10, 2026 (GLOBE NEWSWIRE) -- Rackspace Technology® (NASDAQ:RXT) a leading end-to-end hybrid cloud and AI solutions company, today announced that it will release its fourth quarter 2025 financial results at 8 am ET on Thursday, February 26, 2026. Gajen Kandiah, Chief Executive Officer, and Mark Marino, Chief Financial Officer, will host a conference call on the day of the release (February 26, 2026) at 8:30 am ET to discuss the Company's financial results. Interested parties may access the conference call as follows: To listen to the live webcast or access the replay following the webcast, please visit our IR website at the following link: https://ir.rackspace.com/news-a

    2/10/26 4:06:00 PM ET
    $RXT
    Computer Software: Programming Data Processing
    Technology